On this page

Meeting

COT Meeting: 17th September 2019

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday, 17th September 2019 in Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.

Last updated: 06 July 2021

View as PDF

On this page

Meeting Agenda

  1. Apologies for absence
  2. Draft minutes of July meeting TOX/MIN/2019/04
  3. Matters arising
  4. Update on the Risk Analysis guidelines (reserved business) TOX/2019/44
  5. Discussion paper on the EFSA Opinion on “Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food.” TOX/2019/45
  6. Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes).

    a) Health based guidance value for nicotine 

    i) An overview of strategies to reduce nicotine addiction using low-nicotine-content products TOX/2019/46

    ii) Calculation of a health-based guidance value for inhalation exposure to nicotine based on the study of Lindgren et al. (1999) TOX/2019/47

    b) Flavourings

    i) Paper 10c: Toxicity assessment of flavourings used in E(N)NDS: Menthol TOX/2019/48

    ii) Second draft framework for risk assessment of flavouring compounds in E(N)NDS TOX/2019/49

    c) Literature update to mid-2019  TOX/2019/50
     
  7. Scoping paper on endocrine disruptors and risk assessment TOX/2019/51
  8. Review of hepatotoxicity of dietary turmeric supplements     TOX/2019/52
  9. Paper TOX/2019/53 will be postponed until October
  10. Review of potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years: mycotoxins – additional information TOX/2019/54
  11. SAC update paper for information TOX/2019/55
  12. Any other business

Date of next meeting Tuesday 22nd October 2019 at Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.   

Matters arising

  • Review of potential presence of fumonisins in infant formula in the United Kingdom (UK), and differences between the metabolism of fumonisins in infants and adults. TOX/2019/40
  • Review of potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years: Information on TAs TOX/2019/41
  • Scoping paper on the synthesis and integration of epidemiological and toxicological evidence in risk assessments TOX/2019/42
  • Steviol exposures for children aged 1-5 years based on UK consumption data TOX/2019/43

Media discussed during the meeting

TOX 2019 - 40

Review of potential presence of fumonisins in infant formula in the United Kingdom (UK), and differences between the metabolism of fumonisins in infants and adults (Matters arising)

TOX 2019 - 41

Review of potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years

TOX 2019 - 42

Scoping paper on the synthesis and integration of epidemiological and toxicological evidence in risk assessments

TOX 2019 - 43

Steviol exposures for children aged 1-5 years based on UK consumption data

TOX 2019 - 45

Discussion paper on the EFSA Opinion on “Risk for animal and human health related to the presence of dioxins and dioxin-like PCBs in feed and food.”

TOX 2019 - 46

Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Follow up to Paper 12: An overview of strategies to reduce nicotine addiction using low-nicotine-content products.

TOX 2019 - 47

Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Follow up to Paper 12: Calculation of a health-based guidance value (HBGV) for inhalation exposure to nicotine based on the study of Lindgren et al. (1999).

TOX 2019 - 48

Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Paper 10c: Toxicity assessment of flavourings used in E(N)NDS: Menthol

TOX 2019 - 49

Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Follow up to Paper 11: Second draft framework for risk assessment of flavouring compounds in E(N)NDS

TOX 2019 - 50

Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes). Literature update to mid-2019.

TOX 2019 - 51

Scoping paper on endocrine disruptors and risk assessment

TOX 2019 - 52

Review of hepatotoxicity of dietary turmeric supplements

TOX 2019 - 54

Review of potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years

COT Meeting: 17th September 2019 Agenda

Meeting of the Committee at 10.00am on Tuesday 17th September 2019 at Broadway House Conference Centre, Tothill St, London, SW1H 9NQ

COT Meeting: 17th September 2019 Revised Agenda

Meeting of the Committee at 10.00am on Tuesday 17th September 2019 at Broadway House Conference Centre, Tothill St, London, SW1H 9NQ

Final minutes of the meeting of the Committee on 17th September 2019

Final minutes of the meeting of the Committee held on Tuesday, 17th September 2019 in Broadway House Conference Centre, Tothill St, London, SW1H 9NQ